Page last updated: 2024-11-07

hwa 138

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1-(5-hydroxy-5-methylhexyl)-3-methylxanthine: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID115359
SCHEMBL ID4279105
MeSH IDM0171853

Synonyms (18)

Synonym
1-(5-hydroxy-5-methylhexyl)-3-methyl-3,7-dihydro-1h-purine-2,6-dione
hwa-138
1-(5-hydroxy-5-methylhexyl)-3-methylxanthine
hwa 138
albifylline
1h-purine-2,6-dione, 3,7-dihydro-1-(5-hydroxy-5-methylhexyl)-3-methyl-
a 81-3138
1-(5-hydroxy-5-methylhexyl)-3-methyl-7h-purine-2,6-dione
107767-55-5
unii-a3e4bql3wg
a3e4bql3wg ,
albifylline [inn]
a-81-3138
SCHEMBL4279105
DTXSID20148236
hwa138
Q15633916
AKOS040747788

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
"05 mg/g) alone or in combination with one dose of dexamethasone (0."( Effect of dexamethasone or HWA-138 in combination with antibiotics in experimental Haemophilus influenzae type b infection.
Hawkins, EP; Kaplan, SL; Mason, EO; Rodriguez, AF, 1991
)
0.28

Dosage Studied

ExcerptRelevanceReference
" Animals were chosen randomly and blindly to receive either PTX or HWA 138 in a dosage of 25 mg/kg body weight 1 minute before resuscitation, or they received placebo."( Influence of pentoxifylline and albifylline on liver microcirculation and leukocyte adhesion after hemorrhagic shock in the rat.
Bauer, M; Herzog, C; Maier, M; Marzi, I, 1996
)
0.53
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (22)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (9.09)18.7374
1990's20 (90.91)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.28

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.28 (24.57)
Research Supply Index3.14 (2.92)
Research Growth Index5.41 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.28)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other22 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]